|
|
|
|
|
Selection Criteria
- Patients over the age of 17 years should be referred to the Barnes-Jewish Hospital Lung Transplant Program.
- Children from birth to 17 years of age, with end stage lung disease and:
- evidence of progression of disease,
- medical therapy not effective,
- limited life expectancy (12 - 18 months)
- Likelihood of recurrence of the disease is small.
- No evidence of irreversible organ dysfunction likely to progress or complicate the transplant.
- Patients with irreversible left ventricular dysfunction considered for heart-lung transplant.
- Patients with end-stage liver disease considered for liver-lung transplant.
- No contraindication to immunosuppression.
- Family and patient committed to adherence to complicated medical regimens.
- Child is psychologically stable with a stable family structure.
Selection Criteria
- Patients over the age of 17 years should be referred to the Barnes-Jewish Hospital Lung Transplant Program.
- Children from birth to 17 years of age, with end stage lung disease and:
- evidence of progression of disease,
- medical therapy not effective,
- limited life expectancy (12 - 18 months)
- Likelihood of recurrence of the disease is small.
- No evidence of irreversible organ dysfunction likely to progress or complicate the transplant.
- Patients with irreversible left ventricular dysfunction considered for heart-lung transplant.
- Patients with end-stage liver disease considered for liver-lung transplant.
- No contraindication to immunosuppression.
- Family and patient committed to adherence to complicated medical regimens.
- Child is psychologically stable with a stable family structure.
|
|
|